LONSARI

Alkermes Pharma Ireland Limited

Application Filed: 2012-05-08

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	85619275
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Norman J. Rich
Attorney Name	Norman J. Rich
Law Office Assigned	M40
Employee Name	RICHARDSON, JENNIFER D

Timeline

2012-05-08	Application Filed
2012-10-23	Published for Opposition
2013-12-09	Location: INTENT TO USE SECTION
2016-01-18	Abandon
2016-01-18	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	ALKERMES PHARMA IRELAND LIMITED
Address	CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IE
Legal Entity Type	Corporation
Legal Entity State	IE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Norman J. Rich
Foley & Lardner LLP
Washington Harbour
3000 K Street, N.W.
Washington DC 20007-5109

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases

Type Code

Type

GS0051

Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2012-05-11	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2012-05-15	2 NWOS I:Incoming Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2012-08-22	3 ASGN I:Incoming Correspondence
ASSIGNED TO EXAMINER	2012-08-29	4 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT -WRITTEN	2012-09-05	5 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2012-09-05	6 GNEA F:First Action
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2012-09-05	7 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2012-09-05	8 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2012-09-05	9 CNSA P:
ASSIGNED TO LIE	2012-09-14	10 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2012-09-17	11 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2012-10-03	12 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2012-10-23	13 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2012-10-23	14 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2012-12-18	15 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2013-06-13	16 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2013-06-13	17 EXT1 S:
EXTENSION 1 GRANTED	2013-06-13	18 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-06-15	19 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2013-11-01	20 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2013-12-09	21 AITU A:Allowance for Publication
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2013-12-09	22 AITU A:Allowance for Publication
EXTENSION 2 FILED	2013-11-01	23 EXT2 S:
EXTENSION 2 GRANTED	2013-12-12	24 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-12-13	25 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2014-04-18	26 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2014-04-18	27 EXT3 S:
EXTENSION 3 GRANTED	2014-04-23	28 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2014-04-24	29 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2014-11-17	30 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2014-11-17	31 EXT4 S:
EXTENSION 4 GRANTED	2014-11-24	32 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2014-11-25	33 EXRA E:E-Mail
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2015-01-28	34 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2015-01-28	35 ARAA I:Incoming Correspondence
TEAS EXTENSION RECEIVED	2015-04-27	36 EEXT I:Incoming Correspondence
EXTENSION 5 FILED	2015-04-27	37 EXT5 S:
EXTENSION 5 GRANTED	2015-05-05	38 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED	2015-05-06	39 EXRA O:Outgoing Correspondence
ABANDONMENT - NO USE STATEMENT FILED	2016-01-18	40 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2016-01-19	41 MAB6 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.